Laserfiche WebLink
Discussion Point No. 4: <br /> Is the site plan, circulation, phasing approach and parking ratio acceptable? <br /> The Commission unanimously reserved comments on this discussion point pending the <br /> outcome of the Traffic Impact Analysis (TIA) being prepared as part of the environmental <br /> review for the project. <br /> Discussion Point No. 5: <br /> Is there additional information needed to assist the Commission in its decision on the proposed <br /> project? <br /> Some of the Commissioners requested an economic analysis, an environmental evaluation, <br /> streetscape renderings, increased setbacks and reduced building heights, Leadership in <br /> Energy and Environmental Design (LEED) information, solar project design features and <br /> addressing the comments made by the members of the public during the work session. <br /> PROJECT DESCRIPTION <br /> Proposed Project <br /> The proposed project would include development of a new campus for 10x Genomics, a <br /> biotechnology/life sciences company. 10x Genomics is already headquartered in Pleasanton <br /> and operates existing facilities within the city at Stoneridge Corporate Plaza, and at the Koll <br /> Center. The new campus is intended to allow 10x Genomics to consolidate and expand these <br /> existing operations, with a multi-phased buildout over the next several years. <br /> The proposed project involves constructing up to three new multi-story buildings that would <br /> house a mix of R&D, office and laboratory uses, totaling approximately 381 ,000-square-feet, a <br /> parking structure, and related site improvements (e.g., landscape modifications, utility <br /> installation, stormwater treatment areas, etc.). The project is expected to develop over multiple <br /> phases, as seen in Exhibit B in detail, Figure 2 below, and described further below. <br /> Phase I, which the applicant would seek to develop in the near term (one- to two-years) <br /> includes the construction of an approximately 150,000-square-foot, two and three-story <br /> building (Building 1) at the northern portion of the subject site. This building would be 53-feet <br /> tall to the top of the parapet (65 feet tall with rooftop equipment screen). Approximately 483 <br /> surface parking spaces would be provided for Building 1 (equivalent to approximately 3.2 <br /> spaces per 1,000 sq. ft.). These parking spaces would utilize a portion of the existing surface- <br /> level parking lot on the subject site, which would be resurfaced/restriped and include upgraded <br /> lighting, landscaping, and new sidewalk access. Phase I would also include construction of a <br /> new plaza at the northeast portion of the subject site with pedestrian circulation connecting the <br /> proposed campus to Stoneridge Mall, BART, and adjacent office and residential <br /> developments, although this phase would be designed to facilitate pedestrian connections to <br /> internal open spaces (e.g.: a central campus courtyard with outdoor collaboration spaces for <br /> employees) and buildings developed in future phases of the project. The balance of the subject <br /> site would remain vacant under Phase I and be fenced temporarily and planted with native <br /> grasses. See Figure 3 below for additional detail. <br /> PUD-139 and P20-0973, 10x Genomics, Inc. Planning Commission <br /> 5 of 32 <br /> •.,"\.0'0roQe 0 Q 7 du <br /> �.o�eaae1, lit <br /> • ev, . - <br /> G000Ie Y 4 -. if• Iv ..., <br /> PUD-139 and P20-0973, 10x Genomics, Inc. Planning Commission <br /> 3 of 32 <br />ionally, page 24 of the <br /> PUD-139 and P20-0973, 10x Genomics, Inc. Planning Commission <br /> 2 of 32 <br /> -8- <br />